United States · FDA National Drug Code directory
tadalafil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-854_38689a7c-8af1-e4b0-e063-6394a90a94d8
- Product NDC
- 76420-854
- Form
- TABLET, FILM COATED
- Composition / generic term
- tadalafil
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190326
- Source listing expiry
- 20261231
Source-listed ingredients
- TADALAFIL — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-854-01) · 76420-854-01
- 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-854-05) · 76420-854-05
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-854-30) · 76420-854-30
- 2 BLISTER PACK in 1 CARTON (76420-854-33) / 15 TABLET, FILM COATED in 1 BLISTER PACK · 76420-854-33
- 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-854-60) · 76420-854-60
- 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-854-90) · 76420-854-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →